Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Hlavinkova
Cost-Effectiveness of 2-Dose AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Cost-Effectiveness of Two-Dose Human Papillomavirus Vaccination in Singapore
Singapore Medical Journal
Medicine
Pin5 - 10 Years of Human Papillomavirus Systematic Vaccination in Spain: Forecasting Health Outcomes Considering As04-Hpv16/18 Vaccine Effectiveness Data
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination in Mainland China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed
Cancer
Cancer Research
Oncology
Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Adolescent Girls in Russian Federation
Pediatric pharmacology
Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Erratum To: Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
Open Forum Infectious Diseases
Oncology
Neurology
Pin54 - Cost-Effectiveness of Introducing Men Vaccination Against Human Papillomavirus in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reply to Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed
Cancer
Cancer Research
Oncology
